These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 31449848

  • 1. FLO8 deletion leads to azole resistance by upregulating CDR1 and CDR2 in Candida albicans.
    Li WJ, Liu JY, Shi C, Zhao Y, Meng LN, Wu F, Xiang MJ.
    Res Microbiol; 2019; 170(6-7):272-279. PubMed ID: 31449848
    [Abstract] [Full Text] [Related]

  • 2. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908
    [Abstract] [Full Text] [Related]

  • 3. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 05; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S, Rahkhoodaee F, Raymond M.
    Antimicrob Agents Chemother; 2009 Apr 05; 53(4):1344-52. PubMed ID: 19223631
    [Abstract] [Full Text] [Related]

  • 6. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 Apr 05; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 7. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S, Doluca Dereli M.
    Mikrobiyol Bul; 2014 Apr 05; 48(2):325-34. PubMed ID: 24819270
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
    Zhang MR, Zhao F, Wang S, Lv S, Mou Y, Yao CL, Zhou Y, Li FQ.
    BMC Infect Dis; 2020 Feb 11; 20(1):126. PubMed ID: 32046674
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K, Maki K, Ikeda F, Holmes AR, Lamping E, Niimi M, Monk BC, Cannon RD.
    Antimicrob Agents Chemother; 2006 Apr 11; 50(4):1148-55. PubMed ID: 16569823
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb 11; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 12. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR, Tsao S, Ong SW, Lamping E, Niimi K, Monk BC, Niimi M, Kaneko A, Holland BR, Schmid J, Cannon RD.
    Mol Microbiol; 2006 Oct 11; 62(1):170-86. PubMed ID: 16942600
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH.
    J Mycol Med; 2016 Mar 11; 26(1):35-41. PubMed ID: 26627124
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations.
    Chen LM, Xu YH, Zhou CL, Zhao J, Li CY, Wang R.
    J Int Med Res; 2010 Mar 11; 38(2):536-45. PubMed ID: 20515567
    [Abstract] [Full Text] [Related]

  • 16. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT, Ramsdale M, Ischer F, Sanglard D.
    Microbiology (Reading); 2008 May 11; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PDR16-mediated azole resistance in Candida albicans.
    Saidane S, Weber S, De Deken X, St-Germain G, Raymond M.
    Mol Microbiol; 2006 Jun 11; 60(6):1546-62. PubMed ID: 16796687
    [Abstract] [Full Text] [Related]

  • 19. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.
    FEMS Yeast Res; 2009 Jun 11; 9(4):618-25. PubMed ID: 19416368
    [Abstract] [Full Text] [Related]

  • 20. Contribution of Clinically Derived Mutations in the Gene Encoding the Zinc Cluster Transcription Factor Mrr2 to Fluconazole Antifungal Resistance and CDR1 Expression in Candida albicans.
    Nishimoto AT, Zhang Q, Hazlett B, Morschhäuser J, Rogers PD.
    Antimicrob Agents Chemother; 2019 May 11; 63(5):. PubMed ID: 30833425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.